Dr. D. James Surmeier is an internationally recognized neuroscientist whose research has transformed the understanding of Parkinson’s disease. He has made major contributions to uncovering why dopamine-producing neurons in the substantia nigra are particularly vulnerable to degeneration. His work has revealed the roles of calcium signaling, mitochondrial dysfunction, and metabolic stress in driving neuronal loss, identifying promising targets for therapies that could slow disease progression rather than simply relieve symptoms. Dr. Surmeier has published extensively in leading scientific journals and received numerous honors for his contributions to neuroscience and Parkinson’s disease research. Through his research, collaborations, and mentorship, he continues to advance the development of disease-modifying strategies that offer hope for improved treatments for people living with Parkinson’s disease.